Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Publications

GRAM publications

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.

Antimicrobial Resistance Collaborators None., (2022), Lancet, 399, 629 - 655

The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis

Mestrovic T. et al, (2022), The Lancet Public Health

Mapping local variation in household overcrowding across Africa from 2000 to 2018: a modelling study.

Chipeta MG. et al, (2022), Lancet Planet Health, 6, e670 - e681

Global antibiotic consumption and usage in humans, 2000-18: a spatial modelling study.

Browne AJ. et al, (2021), Lancet Planet Health

The challenges of estimating the human global burden of disease of antimicrobial resistant bacteria.

Dunachie SJ. et al, (2020), Curr Opin Microbiol, 57, 95 - 101

Drug-resistant enteric fever worldwide, 1990 to 2018: a systematic review and meta-analysis.

Browne AJ. et al, (2020), BMC Med, 18

Measuring and mapping the global burden of antimicrobial resistance.

Hay SI. et al, (2018), BMC Med, 16

Drug-resistant bacterial infections: We need urgent action and investment that focus on the weakest link.

Dolecek C. et al, (2022), PLoS Biol, 20

Recent publications by Researchers affiliated with the GRAM project

Drug-resistant bacterial infections: We need urgent action and investment that focus on the weakest link.

Dolecek C. et al, (2022), PLoS Biol, 20

Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019

Ikuta KS. et al, (2022), The Lancet

Evaluation of trends in hospital antimicrobial use in the Lao PDR using repeated point-prevalence surveys-evidence to improve treatment guideline use.

Chansamouth V. et al, (2022), Lancet Reg Health West Pac, 27

The fragmented COVID-19 therapeutics research landscape: a living systematic review of clinical trial registrations evaluating priority pharmacological interventions.

McLean ARD. et al, (2022)

Climate drives the spatiotemporal dynamics of scrub typhus in China.

Ding F. et al, (2022), Glob Chang Biol

Can a conditional financial incentive (CFI) reduce socio-demographic inequalities in home-based HIV testing uptake? A secondary analysis of the HITS clinical trial intervention in rural South Africa.

Inghels M. et al, (2022), Soc Sci Med, 311

Excess Mortality Attributable to Hospital-Acquired Antimicrobial-Resistant Infections: A 2-Year Prospective Surveillance Study in Northeast Thailand.

Lim C. et al, (2022), Open Forum Infect Dis, 9

Modelling the cost-effectiveness of pulse oximetry in primary care management of acute respiratory infection in rural northern Thailand.

Chew R. et al, (2022), Trop Med Int Health

A time-course comparative clinical and immune response evaluation study between the human pathogenic Orientia tsutsugamushi strains: Karp and Gilliam in a rhesus macaque (Macaca mulatta) model.

Inthawong M. et al, (2022), PLoS Negl Trop Dis, 16

Mapping local variation in household overcrowding across Africa from 2000 to 2018: a modelling study.

Chipeta MG. et al, (2022), Lancet Planet Health, 6, e670 - e681

Improving the diagnosis of severe malaria in African children using platelet counts and plasma PfHRP2 concentrations.

Watson JA. et al, (2022), Sci Transl Med, 14

Correction: Assessing the impact of a novel house design on the incidence of malaria in children in rural Africa: study protocol for a household-cluster randomized controlled superiority trial.

Mshamu S. et al, (2022), Trials, 23

Characterizing SARS-CoV-2 Viral Clearance Kinetics to Improve the Design of Antiviral Pharmacometric Studies.

Watson JA. et al, (2022), Antimicrob Agents Chemother

Assessing the impact of a novel house design on the incidence of malaria in children in rural Africa: study protocol for a household-cluster randomized controlled superiority trial.

Mshamu S. et al, (2022), Trials, 23

Comparison of antibody responses and parasite clearance in artemisinin therapeutic efficacy studies in Democratic Republic of Congo and Asia.

Cutts JC. et al, (2022), J Infect Dis

Simultaneous and enantiospecific quantification of primaquine and carboxyprimaquine in human plasma using liquid chromatography-tandem mass spectrometry.

Hanpithakpong W. et al, (2022), Malar J, 21

Attributable Mortality and Excess Length of Stay associated with Third-Generation Cephalosporin Resistant Enterobacterales Bloodstream Infections – a prospective cohort study in Suva, Fiji

Loftus MJ. et al, (2022), Journal of Global Antimicrobial Resistance

Human versus equine intramuscular antitoxin, with or without human intrathecal antitoxin, for the treatment of adults with tetanus: a 2 × 2 factorial randomised controlled trial.

Van Hao N. et al, (2022), Lancet Glob Health, 10, e862 - e872

Blood culture utilization and epidemiology of antimicrobial-resistant bloodstream infections before and during the COVID-19 pandemic in the Indonesian national referral hospital.

Sinto R. et al, (2022), Antimicrob Resist Infect Control, 11

Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling study.

Birger R. et al, (2022), Lancet Infect Dis, 22, 679 - 691

Load More